Works matching AU JIANMING YING

Results: 121

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma.

Published in:

2017

By:

Wenting Huang;
Xuemin Xue;
Ling Shan;
Tian Qiu;
Lei Guo;
Jianming Ying;
Ning Lu;
Huang, Wenting;
Xue, Xuemin;
Shan, Ling;
Qiu, Tian;
Guo, Lei;
Ying, Jianming;
Lu, Ning

Publication type:

journal article

CNDP1 Overexpression by Promoter Hypomethylation Predicts Poor Prognosis and Immunotherapy Response in Mucosal Melanoma.

Published in:

Cancer Science, 2025, v. 116, n. 6, p. 1671, doi. 10.1111/cas.70062

By:

Jia, Jia;
Gu, Junjie;
Gao, Lina;
Liu, Kaihua;
Dai, Jie;
Zhang, Fanshuang;
Yuan, Pei;
Mao, Lili;
Wei, Xiaoting;
Shao, Yang;
Guo, Jun;
Xi, Yanfeng;
Ying, Jianming;
Si, Lu

Publication type:

Article

Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung.

Published in:

NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00569-y

By:

Sun, Li;
Guo, Wei;
Guo, Lei;
Chen, Xiaoxi;
Zhou, Haitao;
Yan, Shi;
Zhao, Gang;
Bao, Hua;
Wu, Xue;
Shao, Yang;
Ying, Jianming;
Lin, Lin

Publication type:

Article

Spatial Transcriptome‐Wide Profiling of Small Cell Lung Cancer Reveals Intra‐Tumoral Molecular and Subtype Heterogeneity.

Published in:

Advanced Science, 2024, v. 11, n. 31, p. 1, doi. 10.1002/advs.202402716

By:

Zhang, Zicheng;
Sun, Xujie;
Liu, Yutao;
Zhang, Yibo;
Yang, Zijian;
Dong, Jiyan;
Wang, Nan;
Ying, Jianming;
Zhou, Meng;
Yang, Lin

Publication type:

Article

Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung Cancer.

Published in:

2018

By:

Qiu, Tian;
Li, Weihua;
Zhang, Tongtong;
Xing, Puyuan;
Huang, Wenting;
Wang, Bingning;
Chu, Lixia;
Guo, Lei;
Liu, Xiuyun;
Li, Yan;
Ying, Jianming;
Li, Junling

Publication type:

journal article

Heterogeneous Response to First-Generation Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancers with Different EGFR Exon 19 Mutations.

Published in:

2020

By:

Xu, Haiyan;
Li, Weihua;
Yang, Guangjian;
Li, Junling;
Yang, Lu;
Xu, Fei;
Yang, Yaning;
Ying, Jianming;
Wang, Yan

Publication type:

journal article

Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancer.

Published in:

2022

By:

Yuan, Pei;
Guo, Changyuan;
Li, Lin;
Ling, Yun;
Guo, Lei;
Ying, Jianming

Publication type:

journal article

Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1345-3

By:

Wenbin Li;
Tian Qiu;
Wenxue Zhi;
Susheng Shi;
Shuangmei Zou;
Yun Ling;
Ling Shan;
Jianming Ying;
Ning Lu

Publication type:

Article

Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.

Published in:

2015

By:

Li, Wenbin;
Qiu, Tian;
Zhi, Wenxue;
Shi, Susheng;
Zou, Shuangmei;
Ling, Yun;
Shan, Ling;
Ying, Jianming;
Lu, Ning

Publication type:

journal article

Pan-cancer analysis to character the clinicopathological and genomic features of KRAS-mutated patients in China.

Published in:

Journal of Cancer Research & Clinical Oncology, 2025, v. 151, n. 2, p. 1, doi. 10.1007/s00432-025-06118-9

By:

Wu, Liyuan;
Rao, Wei;
Guo, Lei;
Zhang, Fanshuang;
Li, Weihua;
Ying, Jianming

Publication type:

Article

Developing an effective quality evaluation strategy of next-generation sequencing for accurate detecting non-small cell lung cancer samples with variable characteristics: a real-world clinical practice.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4889, doi. 10.1007/s00432-022-04388-1

By:

Rao, Wei;
Guo, Lei;
Ling, Yun;
Dong, Lin;
Li, Wenbin;
Ying, Jianming;
Li, Weihua

Publication type:

Article

Exploring the role of TIGIT in patients with Small Cell Lung Cancer as a novel predictor of prognosis and immunotherapy response.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03985-6

By:

Liu, Li;
Wu, Peng;
Wang, Bingzhi;
Dong, Jiyan;
Zhang, Chaoqi;
Liu, Wenchao;
Ying, Jianming

Publication type:

Article

Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2341, doi. 10.1007/s00262-022-03143-2

By:

Song, Peng;
Li, Wenbin;
Wu, Xiaoxuan;
Qian, Zhirong;
Ying, Jianming;
Gao, Shugeng;
He, Jie

Publication type:

Article

Safety, Antitumor Activity, and Pharmacokinetics of Toripalimab, a Programmed Cell Death 1 Inhibitor, in Patients With Advanced Non–Small Cell Lung Cancer: A Phase 1 Trial.

Published in:

JAMA Network Open, 2020, v. 3, n. 10, p. e2013770, doi. 10.1001/jamanetworkopen.2020.13770

By:

Wang, Zhijie;
Ying, Jianming;
Xu, Jiachen;
Yuan, Pei;
Duan, Jianchun;
Bai, Hua;
Guo, Changyuan;
Li, Lin;
Yang, Zhenlin;
Wan, Rui;
Fei, Kailun;
Zhao, Zhe;
Du, Xinyang;
Zhao, Junhui;
Lv, Ning;
Wang, Jie

Publication type:

Article

FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.

Published in:

Carcinogenesis, 2013, v. 34, n. 9, p. 1984, doi. 10.1093/carcin/bgt165

By:

Shu, Xing-sheng;
Li, Lili;
Ji, Mingfang;
Cheng, Yingduan;
Ying, Jianming;
Fan, Yichao;
Zhong, Lan;
Liu, Xiaodong;
Tsao, Sai Wah;
Chan, Anthony TC.;
Tao, Qian

Publication type:

Article

Challenges and improvements in HER2 scoring and histologic evaluation: insights from a national proficiency testing scheme for breast cancer diagnosis in China.

Published in:

Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01884-9

By:

Xue, Xuemin;
Guo, Lei;
Guo, Changyuan;
Xu, Liwei;
Li, Lin;
Yang, Lin;
Wang, Xin;
Rao, Wei;
Yuan, Pei;
Mu, Jiali;
Li, Jiangtao;
Wang, Bingning;
Zhou, Quan;
Xue, Weicheng;
Ma, Fei;
Yang, Wenjing;
Ying, Jianming

Publication type:

Article

Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.

Published in:

PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128202

By:

Li, Wenbin;
Zhi, Wenxue;
Zou, Shuangmei;
Qiu, Tian;
Ling, Yun;
Shan, Ling;
Shi, Susheng;
Ying, Jianming

Publication type:

Article

Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma.

Published in:

PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130447

By:

Shan, Ling;
Qiu, Tian;
Ling, Yun;
Guo, Lei;
Zheng, Bo;
Wang, Bingning;
Li, Wenbin;
Li, Lin;
Ying, Jianming

Publication type:

Article

Detection of ROS1 Gene Rearrangement in Lung Adenocarcinoma: Comparison of IHC, FISH and Real-Time RT-PCR.

Published in:

PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120422

By:

Shan, Ling;
Lian, Fang;
Guo, Lei;
Qiu, Tian;
Ling, Yun;
Ying, Jianming;
Lin, Dongmei

Publication type:

Article

A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer.

Published in:

PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0112765

By:

Ma, Fei;
Ding, Xiaoyan;
Fan, Ying;
Ying, Jianming;
Zheng, Shan;
Lu, Ning;
Xu, Binghe

Publication type:

Article

PIK3CA Gene Mutations and Overexpression: Implications for Prognostic Biomarker and Therapeutic Target in Chinese Esophageal Squamous Cell Carcinoma.

Published in:

PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0103021

By:

Wang, Lin;
Shan, Ling;
Zhang, Shaokai;
Ying, Jianming;
Xue, Liyan;
Yuan, Yanling;
Xie, Yongqiang;
Lu, Ning

Publication type:

Article

Frequent Epigenetic Silencing of the Folate-Metabolising Gene Cystathionine-Beta-Synthase in Gastrointestinal Cancer.

Published in:

PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049683

By:

Hong Zhao;
Qinshan Li;
Jian Wang;
Xianwei Su;
Ka Man Ng;
Tian Qiu;
Ling Shan;
Yun Ling;
Linfang Wang;
Jianqiang Cai;
Jianming Ying

Publication type:

Article

Genome-Wide Screening for Genetic Alterations in Esophageal Cancer by aCGH Identifies 11q13 Amplification Oncogenes Associated with Nodal Metastasis.

Published in:

PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0039797

By:

Jianming Ying;
Ling Shan;
Jisheng Li;
Lan Zhong;
Liyan Xue;
Hong Zhao;
Lili Li;
Langford, Cordelia;
Lei Guo;
Tian Qiu;
Ning Lu;
Qian Tao

Publication type:

Article

The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/β-Catenin Signaling and Is Frequently Silenced in Multiple Tumors.

Published in:

PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027346

By:

Xing-sheng Shu;
Hua Geng;
Lili Li;
Jianming Ying;
Chunhong Ma;
Yajun Wang;
Fan Fong Poon;
Xian Wang;
Ying Ying;
Winnie Yeo;
Srivastava, Gopesh;
Sai Wah Tsao;
Jun Yu;
Sung, Joseph J. Y.;
Shi Huang;
Chan, Anthony T. C.;
Qian Tao

Publication type:

Article

Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma.

Published in:

FASEB Journal, 2019, v. 33, n. 1, p. 254, doi. 10.1096/fj.201701453RR

By:

Lu Wang;
Yu Fan;
Lian Zhang;
Lili Li;
Guanyu Kuang;
Cheng Luo;
Chen Li;
Tingxiu Xiang;
Qian Tao;
Qian Zhang;
Jianming Ying

Publication type:

Article

Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?

Published in:

2018

By:

Yang, Lei;
Dong, Di;
Fang, Mengjie;
Zhu, Yongbei;
Zang, Yali;
Liu, Zhenyu;
Zhang, Hongmei;
Ying, Jianming;
Zhao, Xinming;
Tian, Jie

Publication type:

journal article

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology.

Published in:

Cancer Biology & Medicine, 2019, v. 16, n. 1, p. 189, doi. 10.20892/j.issn.2095-3941.2018.0142

By:

Xuchao Zhang;
Zhiyong Liang;
Shengyue Wang;
Shun Lu;
Yong Song;
Ying Cheng;
Jianming Ying;
Weiping Liu;
Yingyong Hou;
Yangqiu Li;
Yi Liu;
Jun Hou;
Xiufeng Liu;
Jianyong Shao;
Yanhong Tai;
Zheng Wang;
Li Fu;
Hui Li;
Xiaojun Zhou;
Hua Bai

Publication type:

Article

Whole‐genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer.

Published in:

Clinical & Translational Medicine, 2022, v. 12, n. 8, p. 1, doi. 10.1002/ctm2.1014

By:

Gao, Yibo;
Zhao, Hengqiang;
An, Ke;
Liu, Zongzhi;
Hai, Luo;
Li, Renda;
Zhou, Yang;
Zhao, Weipeng;
Jia, Yongsheng;
Wu, Nan;
Li, Lingyu;
Ying, Jianming;
Wang, Jie;
Xu, Binghe;
Wu, Zhihong;
Tong, Zhongsheng;
He, Jie;
Sun, Yingli

Publication type:

Article

Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer.

Published in:

Clinical & Translational Medicine, 2021, v. 11, n. 11, p. 1, doi. 10.1002/ctm2.614

By:

Yang, Chenxuan;
Liu, Jiaxiang;
Zhao, Shuangtao;
Ying, Jianming;
Liu, Yueping;
Ma, Li;
Shang, Qingyao;
Meng, Xiangzhi;
Feng, Kexin;
Zheng, Bo;
Guo, Changyuan;
Wang, Xin;
Wang, Xiang

Publication type:

Article

Self‐Assembled Nanomedicines for Anticancer and Antibacterial Applications.

Published in:

Advanced Healthcare Materials, 2018, v. 7, n. 20, p. N.PAG, doi. 10.1002/adhm.201800670

By:

Zhou, Lingyun;
Qiu, Tian;
Lv, Fengting;
Liu, Libing;
Ying, Jianming;
Wang, Shu

Publication type:

Article

5-Azacitidine induces demethylation of PTPL1 and inhibits growth in non-Hodgkin lymphoma.

Published in:

International Journal of Molecular Medicine, 2015, v. 36, n. 3, p. 698, doi. 10.3892/ijmm.2015.2269

By:

WENMING WANG;
JING WANG;
MIN LI;
JIANMING YING;
HONGMEI JING

Publication type:

Article

WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.

Published in:

Cancer Biology & Therapy, 2010, v. 10, n. 6, p. 617, doi. 10.4161/cbt.10.6.12609

By:

Jisheng Li;
Jianming Ying;
Yichao Fan;
Longtao Wu;
Ying Ying;
Chan, Anthony T.C.;
Srivastava, Gopesh;
Qian Tao

Publication type:

Article

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma.

Published in:

BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11476-z

By:

Xu, Ying;
Li, Zhuo;
Zhou, Yanzhao;
Yang, Yi;
Ouyang, Jingzhong;
Li, Lu;
Huang, Zhen;
Ye, Feng;
Ying, Jianming;
Zhao, Hong;
Zhou, Jinxue;
Zhao, Xinming

Publication type:

Article

Case report: A rare case of tumor-to-tumor metastasis: metastatic lobular breast carcinoma to clear cell renal cell carcinoma.

Published in:

2023

By:

Letian Zhang;
Pei Yuan;
Qi Cao;
Jiali Mu;
Jianming Ying;
Changyuan Guo

Publication type:

Case Study

Histopathology images-based deep learning prediction of prognosis and therapeutic response in small cell lung cancer.

Published in:

NPJ Digital Medicine, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s41746-024-01003-0

By:

Zhang, Yibo;
Yang, Zijian;
Chen, Ruanqi;
Zhu, Yanli;
Liu, Li;
Dong, Jiyan;
Zhang, Zicheng;
Sun, Xujie;
Ying, Jianming;
Lin, Dongmei;
Yang, Lin;
Zhou, Meng

Publication type:

Article

Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay.

Published in:

Scientific Reports, 2015, p. 9211, doi. 10.1038/srep09211

By:

Qiu, Tian;
Lu, Haizhen;
Guo, Lei;
Huang, Wenting;
Ling, Yun;
Shan, Ling;
Li, Wenbin;
Ying, Jianming;
Lv, Ning

Publication type:

Article

Ultra-rapid Idylla™ EGFR mutation screening followed by next-generation sequencing: An integrated solution to molecular diagnosis of non-small cell lung cancer.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1064487

By:

Tian Qiu;
Fanshuang Zhang;
Bo Zheng;
Zitong Feng;
Weihua Li;
Hua Zeng;
Lixia Chu;
Jianming Ying

Publication type:

Article

Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients: A retrospective analysis.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1096589

By:

Huizi Lei;
Pei Yuan;
Changyuan Guo;
Jianming Ying

Publication type:

Article

A Pan-Cancer Analysis of the Oncogenic Role of WD Repeat Domain 74 in Multiple Tumors.

Published in:

Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.860940

By:

Wu, Xiaoxuan;
Song, Peng;
Wang, Shun;
Qian, Zhirong;
Ying, Jianming;
Gao, Shugeng;
Li, Wenbin

Publication type:

Article

Erratum to: Potential unreliability of ALK variant allele frequency in the efficacy prediction of targeted therapy in NSCLC.

Published in:

2024

By:

Rao, Wei;
Liu, Yutao;
Li, Yan;
Guo, Lei;
Qiu, Tian;
Dong, Lin;
Ying, Jianming;
Li, Weihua

Publication type:

Correction Notice

Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy.

Published in:

2024

By:

Jia, Jia;
Mao, Lili;
Lin, Jing;
Li, Wenyu;
Yuan, Pei;
Guo, Lei;
Dai, Jie;
Li, Caili;
Bai, Xue;
Li, Zhongwu;
Chen, Yu;
Guo, Jun;
Ying, Jianming;
Si, Lu

Publication type:

Letter

Potential unreliability of ALK variant allele frequency in the efficacy prediction of targeted therapy in NSCLC.

Published in:

Frontiers of Medicine, 2023, v. 17, n. 3, p. 493, doi. 10.1007/s11684-022-0946-x

By:

Rao, Wei;
Liu, Yutao;
Li, Yan;
Guo, Lei;
Qiu, Tian;
Dong, Lin;
Ying, Jianming;
Li, Weihua

Publication type:

Article

Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer.

Published in:

International Journal of Cancer, 2015, v. 137, n. 3, p. 512, doi. 10.1002/ijc.29405

By:

Li, Xin;
Sun, Lu;
Hou, Junwei;
Gui, Mingming;
Ying, Jianming;
Zhao, Hong;
Lv, Ning;
Meng, Songdong

Publication type:

Article

A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma.

Published in:

Insights into Imaging, 2023, v. 14, n. 1, p. 1, doi. 10.1186/s13244-023-01527-1

By:

Xu, Ying;
Li, Zhuo;
Yang, Yi;
Li, Lu;
Zhou, Yanzhao;
Ouyang, Jingzhong;
Huang, Zhen;
Wang, Sicong;
Xie, Lizhi;
Ye, Feng;
Zhou, Jinxue;
Ying, Jianming;
Zhao, Hong;
Zhao, Xinming

Publication type:

Article

Recent Advances in Conjugated Polymer Materials for Disease Diagnosis.

Published in:

Small, 2016, v. 12, n. 6, p. 696, doi. 10.1002/smll.201501700

By:

Lv, Fengting;
Qiu, Tian;
Liu, Libing;
Ying, Jianming;
Wang, Shu

Publication type:

Article

MET alterations detection platforms and clinical implications in solid tumors: a comprehensive review of literature.

Published in:

Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359231221910

By:

Yuan, Pei;
Xue, Xuemin;
Qiu, Tian;
Ying, Jianming

Publication type:

Article

Pooled Analysis of the Prognostic Significance of Epidermal Growth Factor Receptor (EGFR) Mutational Status in Combination with Other Driver Genomic Alterations in Stage I Resected Invasive Lung Adenocarcinoma for Recurrence-Free Survival: A Population-Based Study

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2025, v. 32, n. 2, p. 760, doi. 10.1245/s10434-024-16528-7

By:

Huang, Yufei;
Zeng, Hui;
Zhang, Guochao;
Ren, Fangzhou;
Yuan, Zhenlong;
Ren, Jingyu;
Xu, Jiaxi;
Song, Zehao;
Li, Wenbin;
Ying, Jianming;
Feng, Feiyue;
Tan, Fengwei

Publication type:

Article

The Battle for Accuracy: Identifying the Most Effective Grading System for Lung Invasive Mucinous Adenocarcinoma.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 9, p. 5717, doi. 10.1245/s10434-024-15541-0

By:

Jia, Jia;
Zhang, Guochao;
Wei, LuoPei;
Qi, Linlin;
Wang, Xiaojun;
Li, Lin;
Zeng, Hua;
Wang, Jianwei;
Xue, Qi;
Ying, Jianming;
Xue, Liyan

Publication type:

Article

Efficacy of third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in advanced NSCLC with different T790M statuses tested via digital droplet polymerase chain reaction ddPCR and next-generation sequencing.

Published in:

Expert Review of Anticancer Therapy, 2024, v. 24, n. 3/4, p. 183, doi. 10.1080/14737140.2024.2334807

By:

Xu, Ziyi;
Li, Yan;
Wang, Lin;
Hao, Xuezhi;
Ying, Jianming;
Li, Junling;
Xing, Puyuan

Publication type:

Article

Single-cell RNA sequencing and spatial transcriptomics of esophageal squamous cell carcinoma with lymph node metastases.

Published in:

Experimental & Molecular Medicine EMM, 2025, v. 57, n. 1, p. 59, doi. 10.1038/s12276-024-01369-x

By:

Guo, Wei;
Zhou, Bolun;
Dou, Lizhou;
Guo, Lei;
Li, Yong;
Qin, Jianjun;
Wang, Zhen;
Huai, Qilin;
Xue, Xuemin;
Li, Yin;
Ying, Jianming;
Xue, Qi;
Gao, Shugeng;
He, Jie

Publication type:

Article